Rohto Pharmaceutical Co.,Ltd. (4527.T) JPX

Currency In JPY

AD

Valuation

Market Cap544.01B
Enterprise Value517.44B
P/E Ratio16.28
PEG Ratio1.46
Price/Sales Ratio1.62
Price/Book Ratio1.85
Enterprise/Revenue1.54
Enterprise/EBITDA8.11

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.1
Operating Margin0.12
AD

Management Effectiveness

Return On Assets0.07
Return On Equity0.12

Income Statement

Revenue343.73B
Revenue/Share1,520.89
Gross Profit182.96B
EBITDA65.48B
Net Income34.25B
Diluted EPS145.29

Balance Sheet

Total Cash86.82B
Total Cash/Share384.14
Total Debt60.24B
Total Debt/Equity0.2
Current Ratio2.04
Book Value Per Share1,416.7

Price History

52-Week Change19.29
52-Week High2,703
52-Week Low2,040.5
Moving Average 50 Days2,398.88
Moving Average 200 Days2,457.92

Statistics

Average Volume877,108
Shares Outstanding225.96M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate46
Trailing Annual Dividend Yield1.86
Payout Ratio0
Last Split Factor2:1
Last Split DateDecember 29, 2022
AD